{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:52:06Z","timestamp":1793962326730,"version":"4.8.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejogrb.2025.114041","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:12:07Z","timestamp":1746875527000},"page":"114041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Assessment of parameters associated with ovarian function recovery in premenopausal women with early breast cancer and chemotherapy-induced amenorrhea in real-world clinical practice"],"prefix":"10.1016","volume":"311","author":[{"given":"George","family":"Douganiotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrosini","family":"Markopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Vrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loukas","family":"Kontovinis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114041_b0005","unstructured":"SEER Database - Female Breast Cancer - Cancer Stat Facts. Accessed January 28, 2023. https:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"10.1016\/j.ejogrb.2025.114041_b0010","unstructured":"OECD Family Database 202SF2.3: Age of mothers at childbirth and age-specific fertility. Published online 2022."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5122(95)00969-8","article-title":"The endocrinology of the menopause","volume":"23","author":"Burger","year":"1996","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2013.11.009","article-title":"Fertility after breast cancer treatment","volume":"173","author":"Kasum","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/pbc.23363","article-title":"Gonadal function and parenthood 20 years after treatment for childhood lymphoma: a cross-sectional study","volume":"59","author":"Hamre","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114041_b0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1200\/JCO.2011.37.1989","article-title":"Premature ovarian failure and fertility in long-term survivors of hodgkin\u2019s lymphoma: a European organisation for research and treatment of cancer lymphoma group and groupe d\u2019etude des lymphomes de l\u2019adulte cohort study","volume":"30","author":"Van Der Kaaij","year":"2012","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114041_b0035","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1093\/humrep\/dew224","article-title":"Factors associated with ovarian function recovery after chemotherapy for breast cancer: a systematic review and meta-analysis","volume":"31","author":"Silva","year":"2016","journal-title":"Hum Reprod"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0040","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.fertnstert.2009.03.045","article-title":"Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer","volume":"94","author":"Partridge","year":"2010","journal-title":"Fertil Steril"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114041_b0045","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5005\/jp-journals-10009-1367","article-title":"Ultrasound assessment of ovarian function following radiation therapy","volume":"8","author":"Prompuntagorn","year":"2014","journal-title":"Donald Sch J Ultrasound Obs Gynecol"},{"key":"10.1016\/j.ejogrb.2025.114041_b0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1210\/rp.57.1.257","article-title":"Hormonal changes in the menopause transition","volume":"57","author":"Burger","year":"2002","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.ejogrb.2025.114041_b0055","unstructured":"NCCN Guidelines - Breast Cancer. Accessed January 28, 2023. https:\/\/www.nccn.org\/guidelines\/guidelines-detail?category=1&id=1419."},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0060","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/REP-12-0121","article-title":"What lies behind chemotherapy-induced ovarian toxicity?","volume":"144","author":"Ben-Aharon","year":"2012","journal-title":"Reproduction"},{"key":"10.1016\/j.ejogrb.2025.114041_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/953937","article-title":"Cancer, fertility preservation, and future pregnancy: A comprehensive review","volume":"2012","author":"Matthews","year":"2012","journal-title":"Obstet Gynecol Int"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0070","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz008","article-title":"Cancer treatment-related infertility: A critical review of the evidence","volume":"3","author":"Poorvu","year":"2019","journal-title":"JNCI cancer Spectr"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0075","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaoncol.2015.3251","article-title":"Gonadotropin-releasing hormone agonists for ovarian function preservation in premenopausal women undergoing chemotherapy for early-stage breast cancer: A systematic review and meta-analysis","volume":"2","author":"Munhoz","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ejogrb.2025.114041_b0080","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.2147\/OTT.S95936","article-title":"Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis","volume":"8","author":"Shen","year":"2015","journal-title":"Onco Targets Ther"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114041_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the childhood cancer survivor study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0090","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.114041_b0095","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ogc.2011.05.002","article-title":"The timing of the age at which natural menopause occurs","volume":"38","author":"Gold","year":"2011","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"25","key":"10.1016\/j.ejogrb.2025.114041_b0100","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114041_b0105","first-page":"411","article-title":"An update on ovarian aging and ovarian reserve tests","volume":"9","author":"Amanvermez","year":"2015","journal-title":"Int J Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114041_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.952471","article-title":"Aging conundrum: A perspective for ovarian aging","volume":"13","author":"Wu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114041_b0115","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.annonc.2021.09.019","article-title":"ESMO Clinical practice guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer \u2606","volume":"32","author":"Gennari","year":"2021","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0120","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1803164","article-title":"Tailoring adjuvant endocrine therapy for premenopausal breast cancer","volume":"379","author":"Francis","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114041_b0125","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the anglo celtic group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114041_b0130","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.24835","article-title":"The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer","volume":"116","author":"Abusief","year":"2010","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.ejogrb.2025.114041_b0135","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1002\/cncr.25106","article-title":"Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study","volume":"116","author":"Sukumvanich","year":"2010","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0140","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-008-0071-9","article-title":"Analysis of chemotherapy-induced amenorrhea rates by three different anthracycline and taxane containing regimens for early breast cancer","volume":"115","author":"Han","year":"2009","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.6004\/jnccn.2022.7065","article-title":"Impact of anti-HER2 therapy alone and with weekly paclitaxel on the ovarian reserve of young women with HER2-positive breast cancer","volume":"21","author":"Lambertini","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejogrb.2025.114041_b0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2017.10.021","volume":"89","author":"Schneeweiss","year":"2018","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1406281","article-title":"Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer","volume":"372","author":"Tolaney","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0160","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil Steril"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.maturitas.2011.11.008","article-title":"Measuring anti-M\u00fcllerian hormone for the assessment of ovarian reserve: when and for whom is it indicated?","volume":"71","author":"Anderson","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.ejogrb.2025.114041_b0170","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ejca.2017.10.001","article-title":"The utility of anti-M\u00fcllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer","volume":"87","author":"Anderson","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114041_b0175","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-11-0199","article-title":"Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer","volume":"19","author":"Torino","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejogrb.2025.114041_b0180","article-title":"Resumption or persistence of menstruation after cytotoxic chemotherapy is a prognostic factor for poor disease-free survival in premenopausal patients with early breast cancer","author":"Park","year":"2012","journal-title":"Published online"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114041_b0185","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/GME.0000000000000440","article-title":"Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: A meta-analysis of the literature","volume":"22","author":"Zhou","year":"2015","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114041_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djy094","article-title":"Adjuvant Anti-HER2 Therapy, treatment-related amenorrhea, and survival in premenopausal HER2-positive early breast cancer patients","volume":"111","author":"Lambertini","year":"2019","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2025.114041_b0195","first-page":"102","article-title":"The impact of menstruation persistence or recovery after chemotherapy on survival in young patients with hormone receptor negative breast cancer","volume":"52","author":"van Barele","year":"2020","journal-title":"Breast Off J Eur Soc Mastology"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:42:08Z","timestamp":1774928528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525003173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"alternative-id":["S0301211525003173"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114041","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessment of parameters associated with ovarian function recovery in premenopausal women with early breast cancer and chemotherapy-induced amenorrhea in real-world clinical practice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114041"}}